WallStSmart

Fold Holdings, Inc. Class A Common Stock (FLD)vsRobinhood Markets Inc (HOOD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Robinhood Markets Inc generates 60749% more annual revenue ($4.47B vs $7.35M). HOOD leads profitability with a 42.1% profit margin vs 3.9%. FLD trades at a lower P/E of 1.8x. FLD earns a higher WallStSmart Score of 63/100 (C+).

FLD

Buy

63

out of 100

Grade: C+

Growth: 7.3Profit: 3.0Value: 8.3Quality: 5.0
Piotroski: 4/9

HOOD

Buy

56

out of 100

Grade: C

Growth: 6.7Profit: 8.5Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 0.41
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

FLDUndervalued (+94.7%)

Margin of Safety

+94.7%

Fair Value

$28.08

Current Price

$1.47

$26.61 discount

UndervaluedFair: $28.08Overvalued
HOODSignificantly Overvalued (-439.5%)

Margin of Safety

-439.5%

Fair Value

$13.94

Current Price

$72.54

$58.60 premium

UndervaluedFair: $13.94Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FLD3 strengths · Avg: 10.0/10
P/E RatioValuation
1.8x10/10

Attractively priced relative to earnings

Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
41.2%10/10

Revenue surging 41.2% year-over-year

HOOD5 strengths · Avg: 9.2/10
Profit MarginProfitability
42.1%10/10

Keeps 42 of every $100 in revenue as profit

Operating MarginProfitability
46.5%10/10

Strong operational efficiency at 46.5%

Market CapQuality
$62.19B9/10

Large-cap with strong market position

Return on EquityProfitability
22.0%9/10

Every $100 of equity generates 22 in profit

Revenue GrowthGrowth
26.5%8/10

Revenue surging 26.5% year-over-year

Areas to Watch

FLD4 concerns · Avg: 2.8/10
Market CapQuality
$52.25M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.8%3/10

ROE of 2.8% — below average capital efficiency

Profit MarginProfitability
3.9%3/10

3.9% margin — thin

Free Cash FlowQuality
$-5.03M2/10

Negative free cash flow — burning cash

HOOD4 concerns · Avg: 3.0/10
P/E RatioValuation
33.7x4/10

Premium valuation, high expectations priced in

Debt/EquityHealth
1.683/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-34.5%2/10

Earnings declined 34.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : FLD

The strongest argument for FLD centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 41.2% demonstrates continued momentum.

Bull Case : HOOD

The strongest argument for HOOD centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 42.1% and operating margin at 46.5%. Revenue growth of 26.5% demonstrates continued momentum.

Bear Case : FLD

The primary concerns for FLD are Market Cap, Return on Equity, Profit Margin. Thin 3.9% margins leave little buffer for downturns.

Bear Case : HOOD

The primary concerns for HOOD are P/E Ratio, Debt/Equity, Piotroski F-Score. Debt-to-equity of 1.68 is elevated, increasing financial risk.

Key Dynamics to Monitor

FLD profiles as a hypergrowth stock while HOOD is a growth play — different risk/reward profiles.

HOOD carries more volatility with a beta of 2.48 — expect wider price swings.

FLD is growing revenue faster at 41.2% — sustainability is the question.

FLD generates stronger free cash flow (-5M), providing more financial flexibility.

Bottom Line

FLD scores higher overall (63/100 vs 56/100) and 41.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Fold Holdings, Inc. Class A Common Stock

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Fold Holdings, Inc. (FLD) is a forward-thinking biotechnology company harnessing advanced research methodologies to pioneer innovative therapies aimed at treating severe genetic and rare diseases. With a robust product pipeline supported by proprietary technologies, Fold is committed to reshaping the drug development landscape. The firm actively engages in strategic partnerships that enhance its market access and growth prospects, positioning it as a significant player in the biotechnology sector. By maintaining a strong focus on scientific excellence and patient-centric solutions, Fold Holdings is well-equipped for sustainable growth and value creation in the dynamic healthcare market.

Visit Website →

Robinhood Markets Inc

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Robinhood Markets Inc (HOOD) is a leading fintech innovator that has revolutionized retail investing by offering a commission-free trading platform since 2013. With its intuitive mobile application, the company enables a diverse range of market participants to access stocks, ETFs, options, and cryptocurrencies, fostering financial literacy and inclusivity. Robinhood's commitment to transparency and product innovation, including features like fractional shares and cash management services, solidifies its role as a significant player in the digital brokerage industry, appealing to a new generation of investors looking for accessible and efficient ways to navigate financial markets.

Visit Website →

Want to dig deeper into these stocks?